These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7617724)
21. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001 [TBL] [Abstract][Full Text] [Related]
22. The effect of acute aripiprazole treatment on chemically and electrically induced seizures in mice: The role of nitric oxide. Shafaroodi H; Oveisi S; Hosseini M; Niknahad H; Moezi L Epilepsy Behav; 2015 Jul; 48():35-40. PubMed ID: 26037847 [TBL] [Abstract][Full Text] [Related]
23. Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Akula KK; Dhir A; Kulkarni SK Eur J Pharmacol; 2008 Jun; 587(1-3):129-34. PubMed ID: 18457833 [TBL] [Abstract][Full Text] [Related]
24. An epigenetic intervention interacts with genetic strain differences to modulate the stress-induced reduction of flurazepam's antiseizure efficacy in the mouse. Deutsch SI; Mastropaolo J; Burket JA; Rosse RB Eur Neuropsychopharmacol; 2009 Jun; 19(6):398-401. PubMed ID: 19189880 [TBL] [Abstract][Full Text] [Related]
25. Anticonvulsant effect of dextrometrophan on pentylenetetrazole-induced seizures in mice: Involvement of nitric oxide and N-methyl-d-aspartate receptors. Mohseni G; Ostadhadi S; Akbarian R; Chamanara M; Norouzi-Javidan A; Dehpour AR Epilepsy Behav; 2016 Dec; 65():49-55. PubMed ID: 27875784 [TBL] [Abstract][Full Text] [Related]
26. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice. Kim HS; Son YR; Kim SH Life Sci; 1999; 64(26):2463-70. PubMed ID: 10403505 [TBL] [Abstract][Full Text] [Related]
27. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842 [TBL] [Abstract][Full Text] [Related]
28. The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test. Khan MI; Ostadhadi S; Zolfaghari S; Ejtemaei Mehr S; Hassanzadeh G; Dehpour AR Neurosci Lett; 2016 Jan; 612():52-61. PubMed ID: 26679225 [TBL] [Abstract][Full Text] [Related]
29. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice. Wlaź P; Baran H; Löscher W Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343 [TBL] [Abstract][Full Text] [Related]
30. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia. Hicks CA; Ward MA; Swettenham JB; O'Neill MJ Eur J Pharmacol; 1999 Sep; 381(2-3):113-9. PubMed ID: 10554878 [TBL] [Abstract][Full Text] [Related]
31. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists. Zhu H; Barr GA Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761 [TBL] [Abstract][Full Text] [Related]
32. Glycinergic interventions potentiate the ability of MK 801 to raise the threshold voltage for tonic hindlimb extension in mice. Norris DO; Mastropaolo J; O'Connor DA; Novitzki MR; Deutsch SI Pharmacol Biochem Behav; 1992 Oct; 43(2):609-12. PubMed ID: 1438497 [TBL] [Abstract][Full Text] [Related]
33. The anticonvulsant activity and cerebral protection of chronic lithium chloride via NMDA receptor/nitric oxide and phospho-ERK. Mohammad Jafari R; Ghahremani MH; Rahimi N; Shadboorestan A; Rashidian A; Esmaeili J; Ejtemaei Mehr S; Dehpour AR Brain Res Bull; 2018 Mar; 137():1-9. PubMed ID: 29102713 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of NO-synthase inhibitor and NMDA antagonist on generation of nitric oxide and release of amino acids and acetylcholine in the rat brain elicited by amphetamine neurotoxicity. Bashkatova V; Kraus MM; Vanin A; Hornick A; Prast H Ann N Y Acad Sci; 2004 Oct; 1025():221-30. PubMed ID: 15542720 [TBL] [Abstract][Full Text] [Related]
35. Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase. Itoh K; Watanabe M Neuroscience; 2009 Mar; 159(2):735-43. PubMed ID: 19162139 [TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like effect of folic acid: Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Brocardo Pde S; Budni J; Lobato KR; Kaster MP; Rodrigues AL Eur J Pharmacol; 2008 Nov; 598(1-3):37-42. PubMed ID: 18789921 [TBL] [Abstract][Full Text] [Related]
37. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists against seizures induced by homocysteine in immature rats. Folbergrová J Exp Neurol; 1997 Jun; 145(2 Pt 1):442-50. PubMed ID: 9217080 [TBL] [Abstract][Full Text] [Related]
38. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist. Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888 [TBL] [Abstract][Full Text] [Related]
39. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. Gidday JM; Shah AR; Maceren RG; Wang Q; Pelligrino DA; Holtzman DM; Park TS J Cereb Blood Flow Metab; 1999 Mar; 19(3):331-40. PubMed ID: 10078885 [TBL] [Abstract][Full Text] [Related]